ADHD Research News
New ADHD research studies referenced in this week's ADHD in the News:
- Baranger, David A. A., et al. “Prenatal Cannabis Exposure, the Brain, and Psychopathology during Early Adolescence.” Nature Mental Health (July 4, 2024): 1-12. DOI: 10.1038/s44220-024-00281-7.
- Referenced in “How may cannabis affect neurodevelopment when exposed in the womb? (News-Medical.net, July 9, 2024)”
- Jakobsson Støre, Siri, et al. “The Relationship Between Social Anxiety Disorder and ADHD in Adolescents and Adults: A Systematic Review.” Journal of Attention Disorders 28, no. 9 (July 2024): 1299-1319. DOI: 10.1177/10870547241247448.
- Referenced in “Here is why social anxiety and ADHD comorbidity requires special attention (PsyPost, July 5, 2024)”
- Jørgensen, Mie Sedoc, et al. “The Course of Borderline Personality Disorder from Adolescence to Early Adulthood: A 5-Year Follow-up Study.” Comprehensive Psychiatry 132 (July 2024): 152478. DOI: 10.1016/j.comppsych.2024.152478.
- Referenced in “Adolescent borderline personality disorder linked to high risk of ADHD, schizophrenia in later years (Contemporary PEDS Journal, July 2024)”
- Lim, You Bin, et al. “Comparison of Arterial Spin Labeled MRI (ASL MRI) between ADHD and Control Group (Ages of 6–12).” Scientific Reports 14, no. 1 (June 28, 2024): 14950. DOI: 10.1038/s41598-024-63658-9.
- Referenced in “Scientists Reveal When Key ADHD Traits Develop in Kids (Newsweek, July 11, 2024)”
- Marchi, Mattia, et al. “Investigating the Impact of Poverty on Mental Illness in the UK Biobank Using Mendelian Randomization.” Nature Human Behaviour (July 10, 2024): 1-13. DOI: 10.1038/s41562-024-01919-3.
- Referenced in “Living in poverty due to mental health problems or developing mental health problems because of poverty? It's both (Medical Xpress, July 10, 2024)”
- Scoten, Olivia, et al. “Attention-Deficit/Hyperactivity Disorder in Pregnancy and the Postpartum Period.” American Journal of Obstetrics & Gynecology 231, no. 1 (July 2024): 19-35. DOI: 10.1016/j.ajog.2024.02.297.
- Referenced in “Preconception counseling and planning key to managing ADHD in pregnancy (Contemporary OB/GYN, July 8, 2024)”
- Talbot, Charlotte, et al. “Comparing the Psychological Outcomes of Donor and Non-Donor Conceived People: A Systematic Review.” BJOG: An International Journal of Obstetrics & Gynaecology (June 27, 2024). DOI: 10.1111/1471-0528.17892.
- Referenced in “Sperm and egg donor kids have 'trust issues' and are at increased risk of ADHD if they're kept in the dark about their history, study finds (Daily Mail, July 5, 2024)”
- William, Sandy, et al. “Experience of CBT in Adults with ADHD: A Mixed Methods Study.” Frontiers in Psychiatry 15 (June 18, 2024). DOI: 10.3389/fpsyt.2024.1341624.
- Referenced in “CBT Must Be Adapted for Adults With ADHD (Psychology Today, July 5, 2024)”
- Young, Vanessa M. “Are Polyunsaturated Fatty Acids Effective for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents? A Cochrane Review Summary with Commentary.” Developmental Medicine & Child Neurology 66, no. 5 (May 2024): 551-553. DOI: 10.1111/dmcn.15888.
- Referenced in “Are PUFAs effective for ADHD? (Contemporary Pediatrics, July 5, 2024 | Contemporary PEDS Journal, July 2024)”
Attention-Deficit/Hyperactivity Disorder in Children Ages 5–17 Years: United States, 2020–2022
NCHS Data Brief No. 499, March 2024
Data from the National Center for Health Statistics, National Health Interview Survey, 2020–2022, finds that 11.3% of children ages 5-17 in the U.S have ever been diagnosed with ADHD. See the breakdown by age group, race, ethnicity, family income, and insurance coverage at General Prevalence of ADHD.
Who Provides Outpatient Clinical Care for Adults With ADHD? Analysis of Healthcare Claims by Types of Providers Among Private Insurance and Medicaid Enrollees, 2021
Journal of Attention Disorders, March 18, 2024
This study from CDC researchers and CHADD PAB co-chair, Craig Surman, MD, finds that family practice physicians, psychiatrists, and nurse practitioners/psychiatric nurses were the most common providers for adults using employer-sponsored insurance, although the distribution of provider types varied across states. Lower percentages of adults with Medicaid received ADHD care from physicians. Approximately half of adults receiving outpatient ADHD care received ADHD care by telehealth.
ADHD medication and risk of cardiovascular diseases
Commentary by CHADD PAB member, Russell J. Schachar, MD, on Zhang et al. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases, JAMA Psychiatry, November 22, 2023.
Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults—United States, 2016-2021
Morbidity and Mortality Weekly Report, March 31, 2023
Centers for Disease Control and Prevention
Summary:
What is already known about this topic?
Prescriptions for stimulants, primarily used to treat attention-deficit/ hyperactivity disorder (ADHD), were increasing for adults before the COVID-19 pandemic. Policies enacted during the pandemic expanded access to prescription stimulants via telehealth.
What is added by this report?
The percentage of adolescent and adult females and adult males receiving prescription stimulant fills increased during 2016-2021, particularly during 2020-2021.
What are the implications for public health practice?
Growing recognition of ADHD in adults and increases in prescription stimulant fills raise questions about current adult ADHD care. Development of clinical recommendations for diagnosing and managing adult ADHD could help guide safe and appropriate stimulant prescribing. Evaluation of policies enacted during the pandemic could identify benefits and harms of those policies.